FDA detects sterilization issues at recalled eye drop manufacturing facility

A new report from the FDA alleges that Global Pharma Healthcare, manufacturer of the recalled EzriCare Artificial Tears Lubricant Eye Drops, did not follow the proper protocol to prevent product contamination at its production facilities, according to an April 3 report from CNN.

Read the full post on Becker's ASC